Skip to content

Author

Sylwia Chelstowska

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Validated high throughput microneutralization assay for anti-AAV2 neutralizing antibodies (NAbs) in clinical trials in support of gene therapy 2247247

Recombinant adeno-associated (AAV) viral vectors are being widely used in gene therapy. One of the challenges for AAV-based therapy is the presence of pre-existing neutralizing antibodies (NAbs) that humans develop against AAV throughout life. These NAbs inhibit the binding of viral vector to the cells resulting...

A. Gorbachev, Miriam Frangini, Sylwia Chelstowska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.